HPV Vaccination in Ahmedabad | Cervical Cancer Prevention

HPV vaccination for girls & boys in Ahmedabad by Dr. Kajal J. Shah, a longtime cervical cancer prevention advocate. Safety, schedule, cost & booking at Shaurya Hospital.

Dr. Kajal J. Shah has spent years talking to parents in Ahmedabad about a vaccine most of them had never heard of.

That's changing fast.

On February 28, 2026, Prime Minister Narendra Modi launched India's first nationwide HPV vaccination programme from Ajmer, Rajasthan. It offers a free dose to roughly 1.15 crore 14-year-old girls a year, at government health centers across the country. It's part of the government's Swastha Nari Mission — one of the biggest public health rollouts India has attempted in years.

For a pediatrician who has been running HPV awareness camps and school seminars in Ahmedabad since long before this was national news, this is the moment the conversation finally caught up.

Why this vaccine matters more than most parents realize

Cervical cancer is the second most common cancer among Indian women.

In 2022 alone, India recorded roughly 124,000 to 127,000 new cases, and close to 80,000 deaths.

That's not a small number. India accounts for over 22 percent of cervical cancer deaths worldwide — despite being one country among many.

Part of the reason is screening. Only around 2 percent of eligible women in India get regular cervical cancer screening.

Part of the reason is the virus itself. HPV types 16 and 18 are responsible for roughly 70 percent of cervical cancer cases in India, and most people carrying these HPV types have no symptoms at all until precancerous changes are already underway.

This is exactly why prevention matters more than early detection here. And prevention means vaccination, before exposure ever happens.

Certain factors raise the risk further: early marriage, multiple pregnancies, and poor menstrual hygiene are all documented risk factors specific to the Indian context. Women who are HIV-positive also clear the virus less effectively, raising their risk. None of this is about blame — it's about understanding why India's cervical cancer numbers look the way they do, and why closing the vaccination gap matters as much as it does.

Vaccination doesn't replace screening, and it's worth being upfront about why

One thing worth correcting early: getting vaccinated doesn't mean screening becomes unnecessary later.

The quadrivalent vaccine used in India's national program is expected to prevent around 83 percent of cervical cancers. That's a large majority, not all of them. A newer nonavalent vaccine (Gardasil 9) covers more HPV types, projected to prevent closer to 98 percent.

Either way, some risk remains outside what any vaccine covers. Regular Pap smears and HPV DNA testing later in adulthood still matter for a vaccinated woman, just as they do for anyone else. Vaccination and screening work together. Neither one replaces the other.

How the vaccine actually works, and why age 9 to 14 specifically

The HPV vaccine doesn't treat an existing infection. It can't.

The vaccine uses virus-like particles that train the immune system to recognize specific HPV types, so that if the body encounters the real virus later, it's already prepared.

That's the entire reason age matters so much here. The vaccine has to be given before a person is likely to encounter the virus — which is why the Indian Academy of Paediatrics recommends starting at age 9, with ages 9 to 14 considered the ideal window.

Children vaccinated in this window need only two doses, six months apart, and develop the strongest immune response of any age group.

Teens and young adults aged 15 to 26 can still benefit significantly, but need three doses instead of two. Immunocompromised individuals need three doses regardless of age.

One common misconception worth clearing up directly: the HPV vaccine is not for infants or toddlers. There's no benefit to vaccinating before age 9, and vaccines aren't approved for younger children.

What India's national program actually covers, and what it doesn't

The free government program is specifically for 14-year-old girls, using a single dose of Gardasil-4 — a quadrivalent vaccine protecting against HPV types 16, 18, 6, and 11. Girls turning 15 within 90 days of the campaign launch are also eligible.

It's entirely voluntary, and requires a parent or guardian's informed consent before a single dose is given.

For this specific age group, a single dose has been shown to provide strong, durable protection — comparable to the traditional two-dose schedule.

Here's what it doesn't cover: boys, and girls outside the 14-to-15 window. Both groups can still be vaccinated, just not through the free government program. This is where private HPV vaccination Ahmedabad options, at a hospital like Shaurya, fill the actual gap in coverage.

What about boys?

This is a question Dr. Kajal Shah gets often, and the honest answer surprises a lot of parents: yes, boys benefit directly, not just indirectly.

The Indian Academy of Paediatrics explicitly recommends HPV vaccine for boys too, on the same schedule as girls, using Cervavac or Gardasil 9 specifically.

HPV causes cancers beyond cervical cancer, including cancers that affect men directly, along with genital warts. Vaccinating boys also reduces how much the virus circulates in a community overall — which protects everyone, including girls who haven't been vaccinated yet.

India's free government program doesn't currently include boys. That may change over time, as similar programs in other countries eventually expanded to include them. Until then, boys who want this protection need private vaccination.

What other countries have already seen

India isn't the first to do this, which is actually reassuring. Over 160 countries now include HPV vaccination in their national immunization schedules, some going back to 2007.

Countries that introduced vaccination that early already have close to two decades of real-world data behind them. The pattern is consistent: significant drops in HPV 16 and 18 infections, fewer genital warts, fewer precancerous cervical changes in vaccinated groups, and a broader herd immunity effect across the wider population — including people who were never vaccinated themselves.

India isn't running an experiment here. It's catching up to a preventive measure that has already played out successfully elsewhere, with the evidence already in.

Addressing the question a lot of Gujarati parents are actually asking

It's worth addressing this directly, because avoiding it doesn't make the question go away.

In 2010, seven adolescent girls died during HPV vaccine demonstration projects running in Gujarat and Andhra Pradesh. It understandably alarmed families across the state, and it slowed vaccine confidence in India for years afterward. If you're a parent in Ahmedabad who has heard some version of this story, that reaction was reasonable at the time.

Here's what happened next: a formal investigation into those deaths found no causal link to the vaccine itself. In the years since, HPV vaccines have become among the most extensively studied vaccines in the world, with more than 500 million doses administered globally and no pattern of serious adverse events tied to them.

The real side effects are far more ordinary. A sore arm. Occasionally a headache or mild nausea that clears up within a day or two. Some adolescents feel briefly dizzy right after the injection, which is why it's given while seated or lying down. That's the actual safety profile — not the story that circulated in 2010.

What vaccination at Shaurya Hospital actually looks like

Three vaccines are currently available in India: Cervavac (developed and manufactured in India), Gardasil, and Gardasil 9.

Your child's age, and which specific protection you're prioritizing, determine which one makes sense — exactly the kind of decision worth making in person rather than guessing from an article online.

Private HPV vaccination in India typically costs somewhere in the range of 3,000 to 4,000 rupees per dose, though this varies by vaccine choice and provider.

If your child is anxious about the injection itself, that's normal, and worth mentioning before the visit rather than during it. Dizziness right after the shot is common enough in adolescents that the standard practice is simply to give the vaccine while the child is sitting or lying down, and to have them stay seated for a few minutes afterward. A sore arm for a day or two is the most common after-effect. None of this requires special preparation beyond a normal meal beforehand and mentioning any past fainting during injections to the doctor administering it.

Dr. Kajal J. Shah has spent years running school health camps and community seminars specifically on HPV awareness in Ahmedabad, well before this was a national headline. That's not a marketing line. It's the reason this particular conversation, at this particular hospital, tends to go further than a five-minute vaccine appointment usually allows.

If your child falls in the 9-to-14 window, or you're a parent trying to figure out what to do with a 15-year-old the free government program no longer covers, that's exactly the conversation worth having before deciding anything. A first visit typically covers which vaccine fits your child's age and situation, a straightforward answer to whatever concern brought you in, and the vaccination itself if you're ready to go ahead that same day.

Book a consultation with Dr. Kajal J. Shah at Shaurya Hospital, Paldi, Ahmedabad, or learn more about vaccination services at Shaurya Hospital's Premier Vaccination Center.

Sources

Press Information Bureau, Government of India. "Cervical Cancer Vaccination Campaign Launched." 28 February 2026. PIB press release page (title matched in search; page not opened) and PIB PDF version (opened; title and date verified).